These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 30238819)
1. How far are we from vaccination against Helicobacter pylori infection? Stubljar D; Jukic T; Ihan A Expert Rev Vaccines; 2018 Oct; 17(10):935-945. PubMed ID: 30238819 [TBL] [Abstract][Full Text] [Related]
2. The design of vaccines against Helicobacter pylori and their development. Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic vaccination against Helicobacter pylori in the beagle dog experimental model: safety, immunogenicity, and efficacy. Rossi G; Ruggiero P; Peppoloni S; Pancotto L; Fortuna D; Lauretti L; Volpini G; Mancianti S; Corazza M; Taccini E; Di Pisa F; Rappuoli R; Del Giudice G Infect Immun; 2004 Jun; 72(6):3252-9. PubMed ID: 15155627 [TBL] [Abstract][Full Text] [Related]
4. Immunology and vaccines and nanovaccines for Helicobacter pylori infection. Milani M; Sharifi Y; Rahmati-Yamchi M; Somi MH; Akbarzadeh A Expert Rev Vaccines; 2015 Jun; 14(6):833-40. PubMed ID: 25645086 [TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model. Hoffelner H; Rieder G; Haas R Int J Med Microbiol; 2008 Jan; 298(1-2):151-9. PubMed ID: 17714988 [TBL] [Abstract][Full Text] [Related]
6. The frequency of circulating integrin α4β7 Akter S; Jeverstam F; Lundgren A; Magnusson MK; Walduck A; Qadri F; Bhuiyan TR; Raghavan S Helicobacter; 2019 Dec; 24(6):e12658. PubMed ID: 31502365 [TBL] [Abstract][Full Text] [Related]
7. Inflammation, immunity, and vaccines for Helicobacter pylori infection. Velin D; Straubinger K; Gerhard M Helicobacter; 2016 Sep; 21 Suppl 1():26-9. PubMed ID: 27531535 [TBL] [Abstract][Full Text] [Related]
9. Immunological response of recombinant H. pylori multi-epitope vaccine with different vaccination strategies. Wang B; Pan X; Wang H; Zhou Y; Zhu J; Yang J; Li W Int J Clin Exp Pathol; 2014; 7(10):6559-66. PubMed ID: 25400734 [TBL] [Abstract][Full Text] [Related]
10. The attenuated Salmonella vaccine approach for the control of Helicobacter pylori-related diseases. Gómez-Duarte OG; Bumann D; Meyer TF Vaccine; 1999 Mar; 17(13-14):1667-73. PubMed ID: 10194821 [TBL] [Abstract][Full Text] [Related]
11. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice. Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469 [TBL] [Abstract][Full Text] [Related]
12. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine. Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394 [TBL] [Abstract][Full Text] [Related]
13. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice. Li X; Xing Y; Guo L; Lv X; Song H; Xi T Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988 [TBL] [Abstract][Full Text] [Related]
14. Vaccine development against infection with Helicobacter pylori. Kleanthous H; Lee CK; Monath TP Br Med Bull; 1998; 54(1):229-41. PubMed ID: 9604446 [TBL] [Abstract][Full Text] [Related]
15. [A vaccine against Helicobacter pylori infection]. Presecki V; Katicić M; Kalenić S; Strnad M; Plecko V; Babus V; Dominis M Lijec Vjesn; 2002 Sep; 124 Suppl 1():79-82. PubMed ID: 12592824 [TBL] [Abstract][Full Text] [Related]
16. Antibody Production and Th1-biased Response Induced by an Epitope Vaccine Composed of Cholera Toxin B Unit and Helicobacter pylori Lpp20 Epitopes. Li Y; Chen Z; Ye J; Ning L; Luo J; Zhang L; Jiang Y; Xi Y; Ning Y Helicobacter; 2016 Jun; 21(3):234-48. PubMed ID: 26332255 [TBL] [Abstract][Full Text] [Related]
17. The C-terminally encoded, MHC class II-restricted T cell antigenicity of the Helicobacter pylori virulence factor CagA promotes gastric preneoplasia. Arnold IC; Hitzler I; Engler D; Oertli M; Agger EM; Müller A J Immunol; 2011 Jun; 186(11):6165-72. PubMed ID: 21518972 [TBL] [Abstract][Full Text] [Related]
18. Towards the development of vaccines against Helicobacter pylori: status and issues. Del Giudice G Curr Opin Investig Drugs; 2001 Jan; 2(1):40-4. PubMed ID: 11527009 [TBL] [Abstract][Full Text] [Related]
19. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model. Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531 [TBL] [Abstract][Full Text] [Related]
20. Host Nonresponsiveness Does not Interfere With Vaccine-Mediated Protection Against Gastric Helicobacter Infection. Harbour SN; Mitchell HM; Sutton P Helicobacter; 2015 Jun; 20(3):217-22. PubMed ID: 25683672 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]